Dr. Daniela Katz is a medical oncologist with extensive experience in the treatment of soft tissue sarcomas, bone sarcomas, and breast cancer. She focuses particularly on rare tumors, including desmoid tumors, GIST, and bone tumors.

In her clinical work, Dr. Katz emphasizes individualized treatment planning, taking into account the characteristics of the disease, the patient’s overall condition, and the latest international guidelines.

A significant part of her practice involves complex cases and patients seeking a second opinion or reconsideration of their treatment strategy.

Clinical Specialization

Dr. Daniela Katz specializes in:

Soft tissue sarcomas
Bone sarcomas
Bone tumors
Desmoid tumors
GIST (Gastrointestinal stromal tumors)
Breast cancer
Rare oncological conditions

In her practice, she applies modern treatment approaches, including:

Personalized treatment strategies
Systemic therapy
Targeted therapy
Immunotherapy
Clinical trials

Clinical Experience

Dr. Daniela Katz has worked in several leading oncology centers across Israel, focusing on sarcoma and breast cancer care.

Between 2010 and 2016, she served as a senior oncologist in the oncology department at Hadassah Medical Center in Jerusalem, where she led the sarcoma clinical program.

From 2017 to 2019, she headed the breast cancer and sarcoma clinical activity at Assaf Harofeh Medical Center.

Later, she was appointed Director of the Oncology Institute at Barzilai Medical Center, where she oversaw clinical oncology services and multidisciplinary treatment programs.

Since 2022, Dr. Katz has been leading the sarcoma field within the oncology department at Shaare Zedek Medical Center in Jerusalem.

Medical Approach

Dr. Katz follows a multidisciplinary approach to cancer care. Treatment decisions are made in collaboration with surgeons, orthopedic specialists, radiologists, pathologists, and radiation oncologists.

This approach is particularly important in sarcoma and rare tumor management, where comprehensive evaluation is essential.

Dr. Katz also incorporates the latest clinical research and international treatment guidelines into her clinical decision-making.

Her work focuses on personalized care and careful selection of the most appropriate treatment strategy.

Education and Training

Dr. Katz completed her medical degree at the Hebrew University of Jerusalem.

She later completed her residency in internal medicine at Shaare Zedek Medical Center, followed by specialization in oncology and radiation therapy at Hadassah Medical Center.

She further advanced her training with a dedicated fellowship in sarcoma at a leading cancer center in Houston, Texas, where she gained extensive experience in rare tumors and complex oncologic cases.

Academic Activity

Dr. Daniela Katz is a Senior Lecturer at the Faculty of Medicine, Hebrew University of Jerusalem.

She is actively involved in the education and training of physicians and medical students.

Professional and Public Roles

Member of the National Council for Cancer Prevention, Diagnosis, and Treatment
Member of the Central Committee for Clinical Trials, Ministry of Health
Member of the National Committee for Multicenter Clinical Trials
Head of Sarcoma Forum, Israeli Cancer Association
Member of the Professional Training Committee, Israeli Cancer Association

Research and Clinical Trials

Dr. Katz is actively involved in clinical research, particularly in sarcoma and breast cancer.

She also participates in national clinical research committees and contributes to the development of new treatment strategies.

Publications

Author of scientific publications in sarcoma and breast cancer (PubMed)

Languages

Hebrew
English
Romanian

Private Consultation with Dr. Daniela Katz

If you are exploring additional treatment options, seeking a second opinion, or facing a complex diagnosis, you may schedule a consultation with Dr. Daniela Katz.

📞 Call: +972-73-374-6844
📧 Email: [email protected]
💬 WhatsApp: +972-52-337-3108

FAQ — Dr. Daniela Katz

1. When do patients usually come to see you for sarcoma?

Most people come when things feel uncertain. Sometimes the diagnosis is already there, but the next step isn’t completely clear. Surgery is mentioned. Or chemotherapy. Or just follow-up.

At that point, patients often want to slow down and understand what all of this really means.

Sarcomas are rare, and small details matter. I usually start by reviewing everything carefully — pathology, imaging, previous recommendations. Sometimes we confirm the original plan. Other times we adjust it.

Even when the change is small, it can make a difference.

2. When is it worth getting a second opinion?

Honestly, earlier than most people think.

You don’t need to wait for something to go wrong. If the diagnosis is rare, if treatment sounds complicated, or if something just doesn’t feel clear — that’s already enough reason.

Many patients come just to be sure. Sometimes we confirm the plan. Sometimes we look at things differently.

Either way, it usually helps people feel more confident moving forward.

3. Do you only work with rare tumors?

No. Alongside sarcoma, I also treat many patients with breast cancer. This is a significant part of my practice.

In breast cancer, there are often multiple treatment options, and the goal is to choose the one that best fits the individual patient.

Sometimes we discuss several approaches. Sometimes the decision is straightforward. It really depends on the situation.

4. How do you make treatment decisions?

I usually don’t make decisions quickly. I prefer to understand the full situation first.

I go through the imaging, biopsy results, and previous treatments. If something isn’t clear, I may ask for additional tests.

In more complex cases, I also discuss the situation with colleagues — surgeons, radiologists, radiation oncologists. This is particularly important for sarcoma.

After that, I sit down with the patient and explain the options. My goal is to keep things clear and practical.

5. Do you work with clinical trials?

Yes, I do, but not automatically and not just because the word sounds promising.

I usually bring it up when I feel it may genuinely fit the case in front of me. Sometimes that happens early. Sometimes much later. It depends on the tumor, what was already tried, and how the disease is behaving.

There are situations where a clinical trial opens a real option. There are others where standard treatment is still the better road. So I try to keep that conversation honest. No drama, no pressure. Just a clear discussion of what it means and whether it truly makes sense.

6. Can I start with an online consultation?

Yes, very often that’s how we begin.

I usually ask patients to send the main records in advance — scans, pathology, treatment summaries, blood work if relevant. I like to review things before we speak, so the conversation itself is useful and focused.

Sometimes one online meeting is enough to make the picture much clearer. Sometimes it only helps us define the next step. Either way, it’s often a practical place to start.

7. Do you see patients only from Israel?

No, not at all.

I speak with patients from outside Israel quite regularly. In many cases, the first conversation happens online, especially when someone is trying to understand whether treatment in Israel is the right move, or whether they simply need another opinion before deciding what to do next.

Some continue remotely. Some come to Israel later on. There isn’t one fixed path here.

8. What matters most to you in working with patients?

Probably the way the conversation feels.

People come into oncology appointments carrying a lot — fear, confusion, sometimes exhaustion too. So for me, it’s important not just to discuss treatment, but to make things understandable. Clear. Human.

I don’t think patients need polished speeches. They need honesty. They need room to ask the same question twice, sometimes three times. And they need to feel that someone is actually thinking with them, not just talking at them.

There are no reviews yet. Be the first one to write one.